Leprosy, tuberculoid
Chapter 1:Certain infectious and parasitic diseases
ICD-10 A30.0 is a billable code used to indicate a diagnosis of leprosy, tuberculoid.
Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. Tuberculoid leprosy is one of the two main forms of the disease, characterized by a strong immune response that limits the spread of the bacteria. Patients typically present with a few well-defined skin lesions that are hypopigmented and may be numb due to peripheral nerve damage. The lesions are often accompanied by a loss of sensation and can lead to significant disability if not treated. Tuberculoid leprosy is less contagious than the lepromatous form and is associated with a better prognosis. Diagnosis is primarily clinical, supported by skin smears and biopsies that may reveal the presence of acid-fast bacilli. Treatment involves multi-drug therapy (MDT) with rifampicin and dapsone, which is effective in killing the bacteria and preventing transmission. Early diagnosis and treatment are crucial to prevent complications and disability associated with the disease.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Diagnosis and management of leprosy, including skin lesions and nerve involvement.
Ensure thorough documentation of the patient's history and exposure risk.
Photographic evidence of skin lesions and detailed descriptions of their characteristics.
Evaluation of skin lesions suspected to be leprosy and differential diagnosis.
Document sensory loss and any neurological assessments performed.
Used for follow-up visits for patients with leprosy.
Document history, examination findings, and treatment plan.
Infectious disease specialists should ensure comprehensive notes on treatment adherence.
The primary treatment for tuberculoid leprosy is multi-drug therapy (MDT) consisting of rifampicin and dapsone, which is effective in curing the disease and preventing transmission.
